Abstract
Original Article Sorath Noorani Siddiqui, FCPS; Ayesha Khan, FCPS, FRCS To evaluate the visual outcome and corneal endothelial cell density after Artisan aphakic intraocular lens (IOL) implantation (Ophtec, Groningen, the Netherlands) in pediatric eyes with subluxated lenses. Artisan aphakic IOLs were implanted in 18 eyes of 11 children with subluxated lenses. Idiopathic subluxations and ectopia lentis due to Marfan syndrome were included, whereas subluxations due to trauma or buphthalmos were excluded. Best-corrected visual acuity (BCVA) and endothelial cell density were monitored. Mean postoperative BCVA and endothelial cell density at last follow-up visit were calculated. The age of children at the time of Artisan aphakic IOL implantation ranged from 8 to 16 years (mean: 11.58 ± 2.9 years). Mean follow-up was 9.12 ± 4.30 months. Mean postoperative logarithm of the minimum angle of resolution BCVA was 0.26 ± 0.13 (P = .001) and mean postoperative endothelial cell density was 2,860 ± 435 cells/mm2 (P = .000). Mean endothelial cell loss was 17.1%. Artisan aphakic IOL implantation is a safe surgical choice in the management of ectopia lentis in the pediatric age group. It has minimal complications and is less traumatic to pediatric eyes. However, long-term follow-up of these children is required. [J Pediatr Ophthalmol Strabismus 2013;50(3):178–182.] From the Department of Pediatric Ophthalmology and Strabismus (SNS), Al-Shifa Trust Eye Hospital, Rawalpindi, Pakistan; and the Department of Pediatric Ophthalmology and Strabismus (AK), Montreal Children Hospital, Montreal, Canada. The authors have no financial or proprietary interest in the materials presented herein. Correspondence: Sorath Noorani Siddiqui, FCPS, 46/II Main Khayaban-e-Shamsheer, Phase 5 Defence Housing Authority, Karachi 75500, Pakistan. E-mail: sorathnoorani@yahoo.com 10.3928/01913913-20130108-02 Healio is intended for health care provider use and all comments will be posted at the discretion of the editors. We reserve the right not to post any comments with unsolicited information about medical devices or other products. At no time will Healio be used for medical advice to patients.